The Administrative Core provides operational and financial oversight for the DDRCC. The Core is responsible for administering the DDRCC grant. The Core is responsible for assuring that the Center complies with federal regulations, submits reports on time, and balances the budget. The Center has co-directors: Robert Sandler and R. Balfour Sartor. There are three Assistant Directors, Scott Magness (pilot-feasibility), Evan Dellon (clinical translational research) and Temitope Keku (enrichment and diversity initiatives). An Executive Committee composed of directors, core directors and scientific representatives, establishes goals, sets standards of use of cores, reviews P/F studies, elects members, plans the enrichment program and interacts with the Internal and external advisory boards. An External Advisory Board provides advice and oversight. An Internal Advisory Board provides additional oversight and helps advocate for the Center within the University administration.
The specific aims of the Administrative Core are: 1) To provide the leadership necessary to promote cooperative, successful scientific interactions among a multidisciplinary group of center participants. 2) To establish appropriate instruments of governance, such as the broadly based Executive Committee, Internal Advisory Board and External Advisory Board. The directors and two committees provide ongoing scientific direction and rigorous constructive review of core laboratories, pilot/feasibility studies and the center as a whole. 3) To provide fiscal and administrative oversight necessary for efficient, cost-effective accomplishment of center goals. 4) To maintain records of core use, publications, surveys, pilot/feasibility progress and new grants made possible through DDRCC support. 5) To promote communication to inform the scientific community and the public about the Center and to inform membership about events. 6) To monitor the performance of the Center. 7) To foster training and career development of young investigators. 8) To promote interaction with other DDRCC?s, the NIDDK and other individuals groups and organizations. The Center benefits from considerable institutional support to enable it to accomplish its mission.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Kochar, Bharati; Barnes, Edward L; Long, Millie D et al. (2018) Depression Is Associated With More Aggressive Inflammatory Bowel Disease. Am J Gastroenterol 113:80-85
Tappata, Manaswita; Eluri, Swathi; Perjar, Irina et al. (2018) Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis. Allergy 73:2088-2092
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Dong, Jing; Buas, Matthew F; Gharahkhani, Puya et al. (2018) Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology 154:1273-1281.e3
Azcarate-Peril, M Andrea; Butz, Natasha; Cadenas, Maria Belen et al. (2018) An Attenuated Salmonella enterica Serovar Typhimurium Strain and Galacto-Oligosaccharides Accelerate Clearance of Salmonella Infections in Poultry through Modifications to the Gut Microbiome. Appl Environ Microbiol 84:
Carlson, Alexander L; Xia, Kai; Azcarate-Peril, M Andrea et al. (2018) Infant Gut Microbiome Associated With Cognitive Development. Biol Psychiatry 83:148-159
Lee, Mi Kyeong; Carnes, Megan U; Butz, Natasha et al. (2018) Exposures Related to House Dust Microbiota in a U.S. Farming Population. Environ Health Perspect 126:067001
Evon, D M; Amador, J; Stewart, P et al. (2018) Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy. Aliment Pharmacol Ther 47:1001-1011
Jones, Roshonda B; Fodor, Anthony A; Peery, Anne F et al. (2018) An Aberrant Microbiota is not Strongly Associated with Incidental Colonic Diverticulosis. Sci Rep 8:4951
Busch, Evan L; Galanko, Joseph A; Sandler, Robert S et al. (2018) Lifestyle Factors, Colorectal Tumor Methylation, and Survival Among African Americans and European Americans. Sci Rep 8:9470

Showing the most recent 10 out of 944 publications